Akito Iwanaga
Niigata, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 47 publications
Suppression of popping rates in radiofrequency ablation under perfluorobutane microbubbles for hepatocellular carcinoma.
Journal: Clinical and experimental hepatology
Published: May 26, 2024
Comparison of Local Recurrence Between LEN-TACE and TACE for Hepatocellular Carcinoma According to Lipiodol Accumulation.
Journal: Cancer diagnosis & prognosis
Published: May 02, 2024
Clinical Efficacy and Body Composition Changes with Sodium Glucose Cotransporter 2 Inhibitor/Glucagon-like Peptide-1 Antagonist Combination Therapy in Patients with Type 2 Diabetes Mellitus-associated Nonalcoholic Fatty Liver Disease.
Journal: Internal medicine (Tokyo, Japan)
Published: February 12, 2024
Efficacy of Adding Locoregional Therapy in Non-Complete Remission Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab: A Preliminary Study.
Journal: Anticancer research
Published: November 29, 2023
Risk factors for difficult endoscopic hemostasis for colonic diverticular bleeding and efficacy and safety of transcatheter arterial embolization.
Journal: Medicine
Published: September 15, 2023
Prognostic Value of TACE With Irinotecan-loaded Drug-eluting Beads (DEBIRI) in Patients With Liver Metastases from Unresectable Colorectal Cancer.
Journal: Anticancer research
Published: May 25, 2023
Comparison of Ablation Volume Between Emprint® and Mimapro® Systems for Hepatocellular Carcinoma -A Preliminary Study.
Journal: Journal of hepatocellular carcinoma
Published: March 29, 2023
Ex Vivo Experimental Study of the Ablation Area of Bovine Liver Using STARmed Radiofrequency Ablation.
Journal: In vivo (Athens, Greece)
Published: March 15, 2023
Effects of body composition and liver function after long-term pemafibrate treatment on dyslipidemia-associated non-alcoholic fatty liver disease.
Journal: Clinical and experimental hepatology
Published: February 06, 2023
An Investigation of Popping During Radiofrequency Ablation After Lenvatinib Administration for Hepatocellular Carcinoma.
Journal: In vivo (Athens, Greece)
Published: January 11, 2023
Last Updated: 09/26/2026